ID
35663
Description
Study ID: 103369 Clinical Study ID: 103369 Study Title: A Randomized Phase III Study of Cisplatin Versus Cisplatin plus Topotecan Versus MVAC in Stage IVB, Recurrent or Persistent Squamous Cell Carcinoma of the Cervix Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: Topotecan Study Indication: Cancer
Keywords
Versions (2)
- 3/14/19 3/14/19 -
- 12/31/19 12/31/19 -
Copyright Holder
GSK group of companies
Uploaded on
March 14, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Cisplatin and Topotecan Recurrent or Persistent Carcinoma of the Cervix - 103369
Pathology Report
- StudyEvent: ODM
Description
Primary
Description
Primary Site
Data type
integer
Description
Specify Other
Data type
text
Description
Histology Type
Description
Carciomas
Data type
integer
Description
Sarcomas
Data type
integer
Description
LMP Tumors of the Ovary
Data type
integer
Description
Sex Cord Stromal Tumors
Data type
integer
Description
Germ Cell Tumors
Data type
integer
Description
Other Hystology Types
Data type
integer
Description
Specify Other
Data type
text
Description
Histologic Grade
Description
Specimens
Description
Secondary
Similar models
Pathology Report
- StudyEvent: ODM